Sana Biotechnology Inc vs SkyWest Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while SkyWest Inc trades at $95.26 (market cap $3.94B). The key difference: SkyWest Inc is far larger — about 4.5× Sana Biotechnology Inc's market cap, and SkyWest Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | SKYW | |
|---|---|---|
Market Cap | $873.84M | $3.94B |
Sector | Health | Technology |
52-Week High | $5.92 | $123.72 |
52-Week Low | $2.68 | $78.40 |
Enterprise Value | $848.03M | $5.79B |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →